Cargando…
Molecular Pathology of Lewy Body Diseases
Lewy body diseases are characterized by the presence of Lewy bodies, alpha-synuclein(AS)-positive inclusions in the brain. Since their main component is conformationally modified AS, aggregation of the latter is thought to be a key pathogenic event in these diseases. The analysis of inclusion body c...
Autores principales: | Beyer, Katrin, Domingo-Sàbat, Montserrat, Ariza, Aurelio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671999/ https://www.ncbi.nlm.nih.gov/pubmed/19399218 http://dx.doi.org/10.3390/ijms10030724 |
Ejemplares similares
-
Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood
por: Perez-Roca, Laia, et al.
Publicado: (2018) -
Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy
por: Urbizu, Aintzane, et al.
Publicado: (2020) -
Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022) -
Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014) -
Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Jellinger, Kurt A.
Publicado: (2022)